Department of Neurosurgery, Bagdasar-Arseni University Hospital, Bucharest, Romania.
Faculty of Medicine, University of Oslo, Oslo, Norway.
Acta Oncol. 2022 Jan;61(1):1-6. doi: 10.1080/0284186X.2021.2009562. Epub 2022 Jan 9.
Primary tumours of the spinal cord, spinal meninges, spinal and peripheral nerves comprise a heterogenous group of pathology, dominantly represented by meningioma, nerve sheath tumours (NST) and glioma. Body height and body mass index (BMI) are risk factors for certain brain tumour subgroups, but no other study has specifically assessed height and BMI in relation to primary tumours of the spine and peripheral nerves in women and men.
In this prospective population-based cohort study height and weight were measured in 1.7 million adult Norwegian women and men at baseline. Incident cases of primary tumours arising from the spinal cord, spinal meninges, spinal and peripheral nerves during follow-up were identified by linkage to the National Cancer Registry. Tumour risk was assessed by Cox regression analyses in relation to height and BMI.
During 49 million person-years of follow-up, 857 primary tumours of the spinal cord, spinal meninges, spinal and peripheral nerves were identified. Overweight and obesity were not associated with risk for all tumours or any tumour subgroup. Height was positively associated with risk for all tumours (HR per 10 cm increase: 1.30, 95% CI 1.16-1.46). The association between height and tumour risk varied between tumour subgroups: while height was not significantly associated with NST, height increased the risk for meningioma (HR 1.42, 95% CI 1.13-1.78) and glioma (HR 1.56, 95% CI 1.06-2.28). The strongest association between height and tumour risk was found for the glioma subgroup of ependymoma in women (HR 3.38, 95% CI 1.64-6.94).
This study could not identify overweight and obesity as risk factors for primary tumours of the spinal cord, spinal meninges, spinal and peripheral nerves in women or men. Increasing body height was associated with increased tumour risk overall, but not universal for all tumour subgroups.Importance of the studyPrimary tumours of the spinal cord, spinal meninges, spinal and peripheral nerves have received little focus in epidemiologic studies, although the incidence and histo-pathological tumour subgroups differ significantly from primary brain tumours. Risk factors for these tumours have hardly been assessed in previous studies. Height, overweight and obesity are known risk factors for several cancers, including certain brain tumour subgroups, such as meningioma.This is the first study to report the association between height, overweight and obesity and primary tumours of the spinal cord, spinal meninges, spinal and peripheral nerves. This includes tumour subgroups of meningioma, nerve sheath tumour, glioma and the most common spinal glioma subgroup of ependymoma. While overweight and obesity were not associated with either of the tumour subgroups, an association between increasing body height and risk for spinal meningioma and glioma, including ependymoma, was found. Nerve sheath tumour risk was not associated with increasing body height.
脊髓、脊髓膜、脊髓和周围神经的原发性肿瘤是一组异质性的病理学,主要由脑膜瘤、神经鞘瘤(NST)和神经胶质瘤组成。身高和体重指数(BMI)是某些脑肿瘤亚组的危险因素,但尚无其他研究专门评估身高和 BMI 与女性和男性的脊柱和周围神经原发性肿瘤之间的关系。
在这项前瞻性基于人群的队列研究中,在基线时测量了 170 万挪威成年女性和男性的身高和体重。通过与国家癌症登记处的链接,在随访期间确定了脊髓、脊髓膜、脊髓和周围神经原发性肿瘤的发病情况。通过 Cox 回归分析评估了与身高和 BMI 相关的肿瘤风险。
在 4900 万个人人年的随访期间,共发现 857 例脊髓、脊髓膜、脊髓和周围神经原发性肿瘤。超重和肥胖与所有肿瘤或任何肿瘤亚组的风险均无关联。身高与所有肿瘤的风险呈正相关(每增加 10 厘米,HR:1.30,95%CI:1.16-1.46)。身高与肿瘤风险之间的关联因肿瘤亚组而异:尽管身高与 NST 无显著相关性,但身高增加了脑膜瘤(HR:1.42,95%CI:1.13-1.78)和神经胶质瘤(HR:1.56,95%CI:1.06-2.28)的风险。身高与肿瘤风险之间的最强关联见于女性的室管膜瘤神经胶质瘤亚组(HR:3.38,95%CI:1.64-6.94)。
本研究无法确定超重和肥胖是女性或男性脊髓、脊髓膜、脊髓和周围神经原发性肿瘤的危险因素。身体增高与肿瘤风险增加有关,但并非所有肿瘤亚组都普遍存在。
脊髓、脊髓膜、脊髓和周围神经的原发性肿瘤在流行病学研究中受到的关注较少,尽管其发病率和组织病理学肿瘤亚组与原发性脑肿瘤有显著差异。这些肿瘤的危险因素在以前的研究中几乎没有得到评估。身高、超重和肥胖是包括某些脑肿瘤亚组(如脑膜瘤)在内的多种癌症的已知危险因素。
这是第一项报告身高、超重和肥胖与脊髓、脊髓膜、脊髓和周围神经原发性肿瘤之间关系的研究。这包括脑膜瘤、神经鞘瘤、神经胶质瘤和最常见的脊髓神经胶质瘤亚组室管膜瘤的肿瘤亚组。虽然超重和肥胖与任何肿瘤亚组均无关联,但发现身体增高与脊髓脑膜瘤和神经胶质瘤(包括室管膜瘤)的风险之间存在关联。神经鞘瘤的风险与身体增高无关。